New era of liver transplantation for hepatitis B: A 17-year single-center experience

Annals of Surgery

Volumn 235, Issue 5, 2002, Pages 611-620

  Anselmo, Dean M ^a   Ghobrial, Rafik M ^a   Jung, Lee Chan ^a   Weaver, Michael ^a   Cao, Carlos ^a   Saab, Sammy ^a   Kunder, Greg ^a   Chen, Pauline W ^a   Farmer, Douglas G ^a   Yersiz, Hasan ^a   Baquerizo, Angeles ^a   Geevarghese, Sunil ^a   Han, Steven H ^a   Goldstein, Leonard ^a   Holt, Curtis D ^a   Gornbein, Jeffrey A ^a   Busuttil, Ronald W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE;

ARTICLE; ASIAN; CLINICAL TRIAL; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROPHYLAXIS; REINFECTION; SURVIVAL RATE; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CAUSE OF DEATH; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATITIS B, CHRONIC; HUMANS; IMMUNOGLOBULINS; IMMUNOSUPPRESSIVE AGENTS; LAMIVUDINE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036234286     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200205000-00002     Document Type: Article

References (31)

1. Should liver transplantation be performed for patients with hepatitis B?
2. Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations
3. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications
4. Liver transplantation in European patients with the hepatitis B surface antigen
5. Risk of HBV reinfection after liver transplantation in HBsAg-positive cirrhosis. Primary hepatocellular carcinoma is not a predictor for HBV recurrence
6. Liver transplantation for chronic hepatitis B in Asian males
7. Medical aspects of liver transplantation
8. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization
9. Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIg) prophylaxis after liver transplantation
10. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients
11. Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts
12. Liver transplantation in HBsAg-positive HBV-DNA-negative cirrhotics: Immunoprophylaxis and long-term outcome
13. Hepatitis B infection and liver transplantation
14. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin
15. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis
16. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation
17. Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: Long-term follow-up
18. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen
19. Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation
20. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin
21. Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation
22. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy
23. Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin
24. A 10-year experience of liver transplantation for hepatitis C: Analysis of factors determining outcome in over 500 patients
25. Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization
26. Multiple organ failure after liver transplantation
27. Clinical characteristics affecting the outcome of liver retransplantation
28. Clinical course and survival after liver transplantation for hepatitis B virus infection complicated by hepatocellular carcinoma
29. Assessment of lymphokine-activated killer activity and gamma-interferon production in patients with small hepatocellular carcinomas
30. Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: A comparative study using a matched, untreated cohort